Managing drug-resistant tuberculosis: from new guidelines to clinical practice
Guidelines sessionChairs: R. Duarte (Porto, Portugal), S. Tiberi (London, United Kingdom)
Aims: to present the new guidelines for multidrug-resistant (MDR)-TB; to discuss similarities and differences with the newly published World Health Organization guidelines; to discuss the best management of challenging clinical cases affected by MDR- or extensively drug-resistant-TB, including paediatric cases.